When TGF-β was present, Th17 cells played a pro-cancer role by secreting IL-17 and IL-22, while when IL-1βwas present, Th17 inducing CCL2 and CCL20 expression, DCs, and other immune cells were activated and recruited, resulting the inhibition of COAD. The gene discussed is IL17A; the disease is cancer.